F/M Emerald Life Sciences Innovation ETF (LFSC) Dividend Yield, History & Forecast

F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund (ETF) listed on the NASDAQ Global Select. market capitalization is approximately $122M.

LFSC fund composition

LFSC holds 38 positions, with 57.2% of assets in its ten largest. It charges an expense ratio of 0.54%, and manages $74.7M.

Top 10 holdings

HoldingWeight
COGTCogent Biosciences Inc7.72%
SYRESpyre Therapeutics Inc7.66%
TVTXTravere Therapeutics Inc7.62%
LIVNLivaNova PLC6.88%
CORTCorcept Therapeutics Inc6.34%
GHGuardant Health Inc5.69%
BLLNBilliontoone Inc4.89%
CYTKCytokinetics Inc3.77%
MIRMMirum Pharmaceuticals Inc3.42%
UTHRUnited Therapeutics Corp3.24%

Frequently Asked Questions about F/M Emerald Life Sciences Innovation ETF (LFSC)

What does F/M Emerald Life Sciences Innovation ETF invest in?
The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. Its core objective is to identify companies that are well-positioned for substantial long-term growth and the creation of significant value. As an actively managed fund, LFSC benefits from a highly specialized and experienced team dedicated to conducting in-depth research into complex life sciences firms. The fund primarily targets U.S. equity securities, selecting those that demonstrate strong growth potential. Specific criteria for inclusion involve a company's leadership in...